Delivery Order SPE2DB22D9304-SPE2DB25FSSQ3

Award Date 3/4/25
Potential Completion Date 3/25/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,093.50, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the supply of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product. The contract, valued at $10,093.50, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency responsible for the Department of Defense's (DoD) medical supply chain. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,093.50 firm fixed-price delivery order is for the supply of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product. The award is part of a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026, which enables the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,458.51 firm fixed-price delivery order is for the provision of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a performance period through February 21, 2025. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award, valued at $10,375.53, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a performance period ending on February 21, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,093.50 firm fixed-price delivery order is for the supply of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
This federal contract award, identified as SPE2DB20D9329|SPE2DB24FZK08, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,364.50 firm fixed-price delivery order is for the supply of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with an ultimate completion date of April 30, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,364.50 firm fixed-price delivery order is for the supply of NUPLAZID 34 MG CAPSULE 30S to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $3,458.51 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to provide a specific pharmaceutical product - NUPLAZID 34 MG CAPSULE 30S. The contract has an ultimate completion date of February 26, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,729.00 firm fixed-price delivery order is for the supply of NUPLAZID 34 MG CAPSULE 30S, with a period of performance through September 25, 2024. The contract award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB25FSSQ3
    Delivery Order

This federal contract award, valued at $10,375.53, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the procurement of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product.

The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. DMS Pharmaceutical Group also holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 6/3/25, 9:47 AM